Cristina Ferrario March 12, 2025 268 FLORENCE, Italy — Exacerbations remain one of the major unresolved challenges in the management of chronic obstructive pulmonary disease (COPD), despite the introduction of new therapies. However, recent advancements have shifted the treatment focus from controlling symptoms to significantly reducing the mortality rate. This pivotal change was discussed at...
Tag: <span>COPD</span>
Post
New COPD Treatments Shift Focus From Symptoms to Survival
Cristina Ferrario March 12, 2025 132 FLORENCE, Italy — Exacerbations remain one of the major unresolved challenges in the management of chronic obstructive pulmonary disease (COPD), despite the introduction of new therapies. However, recent advancements have shifted the treatment focus from controlling symptoms to significantly reducing the mortality rate. This pivotal change was discussed at...
Post
Study demonstrates feasibility, effectiveness of mobile care for COPD
by Susan E.W. Spencer, University of Massachusetts Medical School Participant data flow. Credit: Pilot and Feasibility Studies (2024). DOI: 10.1186/s40814-024-01560-x A multimodal, digital community-based intervention was feasible and decreased illness-related distress in treating patients with chronic obstructive pulmonary disease (COPD), according to a study led by UMass Chan Medical School Program in Digital Medicine researchers. Reports from the...
Post
Can drugs like Ozempic help with COPD?
Share on PinterestGLP-1 and SGLT-2 drugs may be the best treatments for people with type 2 diabetes and COPD. Image credit: Visual Vic/Getty Images. Researchers estimate that as of 2019, about 400 million people around the world were living with chronic obstructive pulmonary disease (COPD), with that number expected to hit 600 million by 2050. While anyone...
Post
More Biologics May Be Breaking Through for COPD
Heidi Splete December 10, 2024 0227 Add to Email Alerts New biologic drugs for chronic obstructive pulmonary disease (COPD) are finally here, said Stephen Rennard, MD, in a presentation in a session on new drugs at the 2024 GOLD International COPD Conference. The inflammatory pathways associated with COPD are diverse and offer a range of...
Post
Using genetics to identify individuals with undiagnosed chronic obstructive pulmonary disease
by Mass General Brigham Credit: CC0 Public Domain In a recent study, Mass General Brigham researchers demonstrated that through low-cost genetic samples that can be obtained from a cheek swab or blood test, they can improve identification of people with COPD in the community. Chronic obstructive pulmonary disease (COPD), a disease that restricts the airways and...
Post
COPD is the sixth leading cause of death in the United States
Increased awareness of COPD needed to improve treatments, quality of life for people with chronic lung diseasesReports and Proceedings COPD Foundation FacebookXLinkedInWeChatBlueskyMessageWhatsAppEmail Miami (January 21, 2025) – Chronic lower respiratory diseases, including chronic obstructive pulmonary disease (COPD), are the sixth leading cause of death in the United States, according to the U.S. Centers for Disease Control...
Post
Commonly prescribed medications can increase fall risk and related injuries in people with COPD
by COPD Foundation Credit: Pixabay/CC0 Public Domain People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing drugs, according to a recent study. The research is published in Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation. Chronic obstructive pulmonary disease (COPD) is an inflammatory lung disease, comprising several conditions, including chronic...
Post
Childhood smoking increases a person’s risk of developing COPD
Smoke exposure negatively impacts critical lung development in childhood and adolescencePeer-Reviewed Publication COPD Foundation Miami (January 7, 2025) – Childhood smoking before age 15 increases a person’s risk of developing chronic obstructive pulmonary disease (COPD), according to a new study. The study is published in the November 2024 issue of Chronic Obstructive Pulmonary Diseases: Journal of the...
Post
Study compares single-inhaler triple therapies for treatment of COPD
by Elana Gotkine For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol, according to a study published online Dec. 30 in The BMJ. William B. Feldman, M.D., M.P.H., from Brigham and Women’s Hospital in Boston, and colleagues compared the effectiveness and safety of budesonide-glycopyrrolate-formoterol, a twice-daily metered dose inhaler,...